Adriana Rossi

Stories

Off-the-shelf cancer cell therapy clears major regulatory hurdle toward replacing custom-made treatments

As of May 2026: Presented CB-011 dose escalation data at Tandem 2026

Every approved cancer cell therapy today requires extracting a patient's own cells, engineering them in a lab, and infusing them back. It costs over $400,000 and sometimes takes weeks — long enough that patients' cancer can grow while they wait.

Updated May 30